Quest Diagnostics Incorporated provides diagnostic testing and related services primarily in the United States, with some international operations. The company generates revenue from routine testing (approximately 50%), advanced clinical testing (about 30%), and other services, including risk assessment for the life insurance industry (around 20%). Its customers include patients, healthcare providers, hospitals, and health plans. Factors supporting its endurance include a broad service offering and established brand recognition, while potential limitations involve regulatory changes and competition from other diagnostic service providers.
—
Quest Diagnostics Incorporated provides diagnostic testing and related services primarily in the United States, with some international operations. The company generates revenue from routine testing (approximately 50%), advanced clinical testing (about 30%), and other services, including risk assessment for the life insurance industry (around 20%). Its customers include patients, healthcare providers, hospitals, and health plans. Factors supporting its endurance include a broad service offering and established brand recognition, while potential limitations involve regulatory changes and competition from other diagnostic service providers.
—
Daily adjusted close
Quest Diagnostics Incorporated provides diagnostic testing and related services primarily in the United States, with some international operations. The company generates revenue from routine testing (approximately 50%), advanced clinical testing (about 30%), and other services, including risk assessment for the life insurance industry (around 20%). Its customers include patients, healthcare providers, hospitals, and health plans. Factors supporting its endurance include a broad service offering and established brand recognition, while potential limitations involve regulatory changes and competition from other diagnostic service providers.